APO Research
Talk to an analyst

APO RESEARCH · REPORT

Therapeutic Peptide APIs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Therapeutic Peptide APIs Market Analysis and Forecast 2026-2032

27 December 2025211 pages

Choose your research edition.

Industry ResearchTherapeutic Peptide APIs Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Therapeutic Peptide APIs Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Therapeutic Peptide APIs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Therapeutic Peptide APIs Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Therapeutic Peptide APIs Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Therapeutic Peptide APIs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Therapeutic Peptide APIs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Therapeutic Peptide APIs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Therapeutic Peptide APIs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Therapeutic Peptide APIs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Therapeutic Peptide APIs include AmbioPharm, Aspen API, Bachem, Bio Basic, CordenPharma, CPC Scientific, GenScript, JPT Peptide Technologies and Limitless Biotech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Therapeutic Peptide APIs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Therapeutic Peptide APIs, also provides the sales of main regions and countries. Of the upcoming market potential for Therapeutic Peptide APIs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Therapeutic Peptide APIs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Therapeutic Peptide APIs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Therapeutic Peptide APIs sales, projected growth trends, production technology, application and end-user industry.

Therapeutic Peptide APIs Segment by Company

AmbioPharm

Aspen API

Bachem

Bio Basic

CordenPharma

CPC Scientific

GenScript

JPT Peptide Technologies

Limitless Biotech

Lonza

Piramal Pharma

PolyPeptide

ScinoPharm

Syngene

USV Peptides

Hybio Pharmaceutical

Guangdong Jianyuan Pharmaceutical

Jiangsu Sinopep-Allsino Biopharmaceutical

Zhejiang Peptites Biotech

Cheng Du Sheng Nuo Biotec

Hainan Shuangcheng Pharmaceuticals

Therapeutic Peptide APIs Segment by Type

Bioactive Peptides

Synthetic Peptides

Therapeutic Peptide APIs Segment by Application

Pharmaceuticals

Scientific Research

Other

Therapeutic Peptide APIs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Peptide APIs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Peptide APIs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Peptide APIs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Therapeutic Peptide APIs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Therapeutic Peptide APIs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Therapeutic Peptide APIs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Therapeutic Peptide APIs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Bioactive Peptides Major Manufacturers Table 3. Synthetic Peptides Major Manufacturers Table 4. Global Therapeutic Peptide APIs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pharmaceuticals Major Manufacturers Table 6. Scientific Research Major Manufacturers Table 7. Other Major Manufacturers Table 8. Therapeutic Peptide APIs Industry Trends Table 9. Therapeutic Peptide APIs Industry Drivers Table 10. Therapeutic Peptide APIs Industry Opportunities and Challenges Table 11. Therapeutic Peptide APIs Industry Restraints Table 12. Global Therapeutic Peptide APIs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Therapeutic Peptide APIs Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Therapeutic Peptide APIs Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Therapeutic Peptide APIs Revenue Market Share by Region (2021-2026) Table 16. Global Therapeutic Peptide APIs Revenue Market Share by Region (2027-2032) Table 17. Global Therapeutic Peptide APIs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 18. Global Therapeutic Peptide APIs Sales by Region (2021-2026) & (Tons) Table 19. Global Therapeutic Peptide APIs Sales by Region (2027-2032) & (Tons) Table 20. Global Therapeutic Peptide APIs Sales Market Share by Region (2021-2026) Table 21. Global Therapeutic Peptide APIs Sales Market Share by Region (2027-2032) Table 22. Global Therapeutic Peptide APIs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Therapeutic Peptide APIs Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Therapeutic Peptide APIs Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Therapeutic Peptide APIs Sales Market Share by Manufacturers (2021-2026) Table 26. Global Therapeutic Peptide APIs Sales Price (US$/K G) of Manufacturers (2021-2026) Table 27. Global Therapeutic Peptide APIs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Therapeutic Peptide APIs Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Therapeutic Peptide APIs Manufacturers, Product Type & Application Table 30. Global Therapeutic Peptide APIs Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Therapeutic Peptide APIs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Therapeutic Peptide APIs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Therapeutic Peptide APIs Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Therapeutic Peptide APIs Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Therapeutic Peptide APIs Revenue Market Share by Type (2021-2026) Table 37. Global Therapeutic Peptide APIs Revenue Market Share by Type (2027-2032) Table 38. Global Therapeutic Peptide APIs Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 39. Global Therapeutic Peptide APIs Sales by Type (2021-2026) & (Tons) Table 40. Global Therapeutic Peptide APIs Sales by Type (2027-2032) & (Tons) Table 41. Global Therapeutic Peptide APIs Sales Market Share by Type (2021-2026) Table 42. Global Therapeutic Peptide APIs Sales Market Share by Type (2027-2032) Table 43. Global Therapeutic Peptide APIs Price by Type (2021-2026) & (US$/K G) Table 44. Global Therapeutic Peptide APIs Price by Type (2027-2032) & (US$/K G) Table 45. Global Therapeutic Peptide APIs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Therapeutic Peptide APIs Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Therapeutic Peptide APIs Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Therapeutic Peptide APIs Revenue Market Share by Application (2021-2026) Table 49. Global Therapeutic Peptide APIs Revenue Market Share by Application (2027-2032) Table 50. Global Therapeutic Peptide APIs Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 51. Global Therapeutic Peptide APIs Sales by Application (2021-2026) & (Tons) Table 52. Global Therapeutic Peptide APIs Sales by Application (2027-2032) & (Tons) Table 53. Global Therapeutic Peptide APIs Sales Market Share by Application (2021-2026) Table 54. Global Therapeutic Peptide APIs Sales Market Share by Application (2027-2032) Table 55. Global Therapeutic Peptide APIs Price by Application (2021-2026) & (US$/K G) Table 56. Global Therapeutic Peptide APIs Price by Application (2027-2032) & (US$/K G) Table 57. AmbioPharm Company Information Table 58. AmbioPharm Business Overview Table 59. AmbioPharm Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 60. AmbioPharm Therapeutic Peptide APIs Product Portfolio Table 61. AmbioPharm Recent Development Table 62. Aspen API Company Information Table 63. Aspen API Business Overview Table 64. Aspen API Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 65. Aspen API Therapeutic Peptide APIs Product Portfolio Table 66. Aspen API Recent Development Table 67. Bachem Company Information Table 68. Bachem Business Overview Table 69. Bachem Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 70. Bachem Therapeutic Peptide APIs Product Portfolio Table 71. Bachem Recent Development Table 72. Bio Basic Company Information Table 73. Bio Basic Business Overview Table 74. Bio Basic Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 75. Bio Basic Therapeutic Peptide APIs Product Portfolio Table 76. Bio Basic Recent Development Table 77. CordenPharma Company Information Table 78. CordenPharma Business Overview Table 79. CordenPharma Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 80. CordenPharma Therapeutic Peptide APIs Product Portfolio Table 81. CordenPharma Recent Development Table 82. CPC Scientific Company Information Table 83. CPC Scientific Business Overview Table 84. CPC Scientific Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 85. CPC Scientific Therapeutic Peptide APIs Product Portfolio Table 86. CPC Scientific Recent Development Table 87. GenScript Company Information Table 88. GenScript Business Overview Table 89. GenScript Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 90. GenScript Therapeutic Peptide APIs Product Portfolio Table 91. GenScript Recent Development Table 92. JPT Peptide Technologies Company Information Table 93. JPT Peptide Technologies Business Overview Table 94. JPT Peptide Technologies Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 95. JPT Peptide Technologies Therapeutic Peptide APIs Product Portfolio Table 96. JPT Peptide Technologies Recent Development Table 97. Limitless Biotech Company Information Table 98. Limitless Biotech Business Overview Table 99. Limitless Biotech Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 100. Limitless Biotech Therapeutic Peptide APIs Product Portfolio Table 101. Limitless Biotech Recent Development Table 102. Lonza Company Information Table 103. Lonza Business Overview Table 104. Lonza Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 105. Lonza Therapeutic Peptide APIs Product Portfolio Table 106. Lonza Recent Development Table 107. Piramal Pharma Company Information Table 108. Piramal Pharma Business Overview Table 109. Piramal Pharma Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 110. Piramal Pharma Therapeutic Peptide APIs Product Portfolio Table 111. Piramal Pharma Recent Development Table 112. PolyPeptide Company Information Table 113. PolyPeptide Business Overview Table 114. PolyPeptide Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 115. PolyPeptide Therapeutic Peptide APIs Product Portfolio Table 116. PolyPeptide Recent Development Table 117. ScinoPharm Company Information Table 118. ScinoPharm Business Overview Table 119. ScinoPharm Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 120. ScinoPharm Therapeutic Peptide APIs Product Portfolio Table 121. ScinoPharm Recent Development Table 122. Syngene Company Information Table 123. Syngene Business Overview Table 124. Syngene Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 125. Syngene Therapeutic Peptide APIs Product Portfolio Table 126. Syngene Recent Development Table 127. USV Peptides Company Information Table 128. USV Peptides Business Overview Table 129. USV Peptides Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 130. USV Peptides Therapeutic Peptide APIs Product Portfolio Table 131. USV Peptides Recent Development Table 132. Hybio Pharmaceutical Company Information Table 133. Hybio Pharmaceutical Business Overview Table 134. Hybio Pharmaceutical Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 135. Hybio Pharmaceutical Therapeutic Peptide APIs Product Portfolio Table 136. Hybio Pharmaceutical Recent Development Table 137. Guangdong Jianyuan Pharmaceutical Company Information Table 138. Guangdong Jianyuan Pharmaceutical Business Overview Table 139. Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 140. Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Product Portfolio Table 141. Guangdong Jianyuan Pharmaceutical Recent Development Table 142. Jiangsu Sinopep-Allsino Biopharmaceutical Company Information Table 143. Jiangsu Sinopep-Allsino Biopharmaceutical Business Overview Table 144. Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 145. Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Product Portfolio Table 146. Jiangsu Sinopep-Allsino Biopharmaceutical Recent Development Table 147. Zhejiang Peptites Biotech Company Information Table 148. Zhejiang Peptites Biotech Business Overview Table 149. Zhejiang Peptites Biotech Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 150. Zhejiang Peptites Biotech Therapeutic Peptide APIs Product Portfolio Table 151. Zhejiang Peptites Biotech Recent Development Table 152. Cheng Du Sheng Nuo Biotec Company Information Table 153. Cheng Du Sheng Nuo Biotec Business Overview Table 154. Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 155. Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Product Portfolio Table 156. Cheng Du Sheng Nuo Biotec Recent Development Table 157. Hainan Shuangcheng Pharmaceuticals Company Information Table 158. Hainan Shuangcheng Pharmaceuticals Business Overview Table 159. Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 160. Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Product Portfolio Table 161. Hainan Shuangcheng Pharmaceuticals Recent Development Table 162. North America Therapeutic Peptide APIs Revenue by Type (2021-2026) & (US$ Million) Table 163. North America Therapeutic Peptide APIs Revenue by Type (2027-2032) & (US$ Million) Table 164. North America Therapeutic Peptide APIs Sales by Type (2021-2026) & (Tons) Table 165. North America Therapeutic Peptide APIs Sales by Type (2027-2032) & (Tons) Table 166. North America Therapeutic Peptide APIs Sales Price by Type (2021-2026) & (US$/K G) Table 167. North America Therapeutic Peptide APIs Sales Price by Type (2027-2032) & (US$/K G) Table 168. North America Therapeutic Peptide APIs Revenue by Application (2021-2026) & (US$ Million) Table 169. North America Therapeutic Peptide APIs Revenue by Application (2027-2032) & (US$ Million) Table 170. North America Therapeutic Peptide APIs Sales by Application (2021-2026) & (Tons) Table 171. North America Therapeutic Peptide APIs Sales by Application (2027-2032) & (Tons) Table 172. North America Therapeutic Peptide APIs Sales Price by Application (2021-2026) & (US$/K G) Table 173. North America Therapeutic Peptide APIs Sales Price by Application (2027-2032) & (US$/K G) Table 174. North America Therapeutic Peptide APIs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. North America Therapeutic Peptide APIs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. North America Therapeutic Peptide APIs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. North America Therapeutic Peptide APIs Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 178. North America Therapeutic Peptide APIs Sales by Country (2021-2026) & (Tons) Table 179. North America Therapeutic Peptide APIs Sales by Country (2027-2032) & (Tons) Table 180. North America Therapeutic Peptide APIs Sales Price by Country (2021-2026) & (US$/K G) Table 181. North America Therapeutic Peptide APIs Sales Price by Country (2027-2032) & (US$/K G) Table 182. United States Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 183. Canada Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 184. Europe Therapeutic Peptide APIs Revenue by Type (2021-2026) & (US$ Million) Table 185. Europe Therapeutic Peptide APIs Revenue by Type (2027-2032) & (US$ Million) Table 186. Europe Therapeutic Peptide APIs Sales by Type (2021-2026) & (Tons) Table 187. Europe Therapeutic Peptide APIs Sales by Type (2027-2032) & (Tons) Table 188. Europe Therapeutic Peptide APIs Sales Price by Type (2021-2026) & (US$/K G) Table 189. Europe Therapeutic Peptide APIs Sales Price by Type (2027-2032) & (US$/K G) Table 190. Europe Therapeutic Peptide APIs Revenue by Application (2021-2026) & (US$ Million) Table 191. Europe Therapeutic Peptide APIs Revenue by Application (2027-2032) & (US$ Million) Table 192. Europe Therapeutic Peptide APIs Sales by Application (2021-2026) & (Tons) Table 193. Europe Therapeutic Peptide APIs Sales by Application (2027-2032) & (Tons) Table 194. Europe Therapeutic Peptide APIs Sales Price by Application (2021-2026) & (US$/K G) Table 195. Europe Therapeutic Peptide APIs Sales Price by Application (2027-2032) & (US$/K G) Table 196. Europe Therapeutic Peptide APIs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. Europe Therapeutic Peptide APIs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. Europe Therapeutic Peptide APIs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. Europe Therapeutic Peptide APIs Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 200. Europe Therapeutic Peptide APIs Sales by Country (2021-2026) & (Tons) Table 201. Europe Therapeutic Peptide APIs Sales by Country (2027-2032) & (Tons) Table 202. Europe Therapeutic Peptide APIs Sales Price by Country (2021-2026) & (US$/K G) Table 203. Europe Therapeutic Peptide APIs Sales Price by Country (2027-2032) & (US$/K G) Table 204. Germany Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 205. France Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 206. U.K. Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 207. Italy Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 208. Russia Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 209. Spain Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 210. Netherlands Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 211. Switzerland Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 212. Sweden Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 213. Poland Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 214. China Therapeutic Peptide APIs Revenue by Type (2021-2026) & (US$ Million) Table 215. China Therapeutic Peptide APIs Revenue by Type (2027-2032) & (US$ Million) Table 216. China Therapeutic Peptide APIs Sales by Type (2021-2026) & (Tons) Table 217. China Therapeutic Peptide APIs Sales by Type (2027-2032) & (Tons) Table 218. China Therapeutic Peptide APIs Sales Price by Type (2021-2026) & (US$/K G) Table 219. China Therapeutic Peptide APIs Sales Price by Type (2027-2032) & (US$/K G) Table 220. China Therapeutic Peptide APIs Revenue by Application (2021-2026) & (US$ Million) Table 221. China Therapeutic Peptide APIs Revenue by Application (2027-2032) & (US$ Million) Table 222. China Therapeutic Peptide APIs Sales by Application (2021-2026) & (Tons) Table 223. China Therapeutic Peptide APIs Sales by Application (2027-2032) & (Tons) Table 224. China Therapeutic Peptide APIs Sales Price by Application (2021-2026) & (US$/K G) Table 225. China Therapeutic Peptide APIs Sales Price by Application (2027-2032) & (US$/K G) Table 226. Asia Therapeutic Peptide APIs Revenue by Type (2021-2026) & (US$ Million) Table 227. Asia Therapeutic Peptide APIs Revenue by Type (2027-2032) & (US$ Million) Table 228. Asia Therapeutic Peptide APIs Sales by Type (2021-2026) & (Tons) Table 229. Asia Therapeutic Peptide APIs Sales by Type (2027-2032) & (Tons) Table 230. Asia Therapeutic Peptide APIs Sales Price by Type (2021-2026) & (US$/K G) Table 231. Asia Therapeutic Peptide APIs Sales Price by Type (2027-2032) & (US$/K G) Table 232. Asia Therapeutic Peptide APIs Revenue by Application (2021-2026) & (US$ Million) Table 233. Asia Therapeutic Peptide APIs Revenue by Application (2027-2032) & (US$ Million) Table 234. Asia Therapeutic Peptide APIs Sales by Application (2021-2026) & (Tons) Table 235. Asia Therapeutic Peptide APIs Sales by Application (2027-2032) & (Tons) Table 236. Asia Therapeutic Peptide APIs Sales Price by Application (2021-2026) & (US$/K G) Table 237. Asia Therapeutic Peptide APIs Sales Price by Application (2027-2032) & (US$/K G) Table 238. Asia Therapeutic Peptide APIs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 239. Asia Therapeutic Peptide APIs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 240. Asia Therapeutic Peptide APIs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 241. Asia Therapeutic Peptide APIs Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 242. Asia Therapeutic Peptide APIs Sales by Country (2021-2026) & (Tons) Table 243. Asia Therapeutic Peptide APIs Sales by Country (2027-2032) & (Tons) Table 244. Asia Therapeutic Peptide APIs Sales Price by Country (2021-2026) & (US$/K G) Table 245. Asia Therapeutic Peptide APIs Sales Price by Country (2027-2032) & (US$/K G) Table 246. Japan Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 247. South Korea Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 248. India Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 249. Australia Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 250. Taiwan Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 251. Southeast Asia Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 252. SAMEA Therapeutic Peptide APIs Revenue by Type (2021-2026) & (US$ Million) Table 253. SAMEA Therapeutic Peptide APIs Revenue by Type (2027-2032) & (US$ Million) Table 254. SAMEA Therapeutic Peptide APIs Sales by Type (2021-2026) & (Tons) Table 255. SAMEA Therapeutic Peptide APIs Sales by Type (2027-2032) & (Tons) Table 256. SAMEA Therapeutic Peptide APIs Sales Price by Type (2021-2026) & (US$/K G) Table 257. SAMEA Therapeutic Peptide APIs Sales Price by Type (2027-2032) & (US$/K G) Table 258. SAMEA Therapeutic Peptide APIs Revenue by Application (2021-2026) & (US$ Million) Table 259. SAMEA Therapeutic Peptide APIs Revenue by Application (2027-2032) & (US$ Million) Table 260. SAMEA Therapeutic Peptide APIs Sales by Application (2021-2026) & (Tons) Table 261. SAMEA Therapeutic Peptide APIs Sales by Application (2027-2032) & (Tons) Table 262. SAMEA Therapeutic Peptide APIs Sales Price by Application (2021-2026) & (US$/K G) Table 263. SAMEA Therapeutic Peptide APIs Sales Price by Application (2027-2032) & (US$/K G) Table 264. SAMEA Therapeutic Peptide APIs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 265. SAMEA Therapeutic Peptide APIs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 266. SAMEA Therapeutic Peptide APIs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 267. SAMEA Therapeutic Peptide APIs Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 268. SAMEA Therapeutic Peptide APIs Sales by Country (2021-2026) & (Tons) Table 269. SAMEA Therapeutic Peptide APIs Sales by Country (2027-2032) & (Tons) Table 270. SAMEA Therapeutic Peptide APIs Sales Price by Country (2021-2026) & (US$/K G) Table 271. SAMEA Therapeutic Peptide APIs Sales Price by Country (2027-2032) & (US$/K G) Table 272. Brazil Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 273. Argentina Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 274. Chile Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 275. Colombia Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 276. Peru Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 277. Saudi Arabia Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 278. Israel Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 279. UAE Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 280. Turkey Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 281. Iran Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 282. Egypt Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Table 283. Key Raw Materials Table 284. Raw Materials Key Suppliers Table 285. Therapeutic Peptide APIs Distributors List Table 286. Therapeutic Peptide APIs Customers List Table 287. Research Programs/Design for This Report Table 288. Authors List of This Report Table 289. Secondary Sources Table 290. Primary Sources List of Figures Figure 1. Therapeutic Peptide APIs Image Figure 2. Global Therapeutic Peptide APIs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Therapeutic Peptide APIs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Bioactive Peptides Image Figure 5. Synthetic Peptides Image Figure 6. Global Therapeutic Peptide APIs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Therapeutic Peptide APIs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pharmaceuticals Image Figure 9. Scientific Research Image Figure 10. Other Image Figure 11. Global Therapeutic Peptide APIs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Therapeutic Peptide APIs Revenue (2021-2032) & (US$ Million) Figure 13. Global Therapeutic Peptide APIs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Therapeutic Peptide APIs Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Therapeutic Peptide APIs Revenue Market Share by Region (2021-2032) Figure 16. Global Therapeutic Peptide APIs Sales (2021-2032) & (Tons) Figure 17. Global Therapeutic Peptide APIs Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 18. Global Therapeutic Peptide APIs Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Therapeutic Peptide APIs Sales YoY (2021-2032) & (Tons) Figure 20. Europe Therapeutic Peptide APIs Sales YoY (2021-2032) & (Tons) Figure 21. China Therapeutic Peptide APIs Sales YoY (2021-2032) & (Tons) Figure 22. Asia (Excluding China) Therapeutic Peptide APIs Sales YoY (2021-2032) & (Tons) Figure 23. South America, Middle East and Africa Therapeutic Peptide APIs Sales YoY (2021-2032) & (Tons) Figure 24. Global Therapeutic Peptide APIs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Therapeutic Peptide APIs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Therapeutic Peptide APIs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Therapeutic Peptide APIs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Therapeutic Peptide APIs Revenue Market Share by Type (2021-2032) Figure 30. Global Therapeutic Peptide APIs Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 31. Global Therapeutic Peptide APIs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Therapeutic Peptide APIs Sales Market Share by Type (2021-2032) Figure 33. Global Therapeutic Peptide APIs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Therapeutic Peptide APIs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Therapeutic Peptide APIs Revenue Market Share by Application (2021-2032) Figure 36. Global Therapeutic Peptide APIs Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 37. Global Therapeutic Peptide APIs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Therapeutic Peptide APIs Sales Market Share by Application (2021-2032) Figure 39. North America Therapeutic Peptide APIs Revenue Share by Type (2021-2032) Figure 40. North America Therapeutic Peptide APIs Sales Share by Type (2021-2032) Figure 41. North America Therapeutic Peptide APIs Revenue Share by Application (2021-2032) Figure 42. North America Therapeutic Peptide APIs Sales Share by Application (2021-2032) Figure 43. North America Therapeutic Peptide APIs Revenue Share by Country (2021-2032) Figure 44. North America Therapeutic Peptide APIs Sales Share by Country (2021-2032) Figure 45. Europe Therapeutic Peptide APIs Revenue Share by Type (2021-2032) Figure 46. Europe Therapeutic Peptide APIs Sales Share by Type (2021-2032) Figure 47. Europe Therapeutic Peptide APIs Revenue Share by Application (2021-2032) Figure 48. Europe Therapeutic Peptide APIs Sales Share by Application (2021-2032) Figure 49. Europe Therapeutic Peptide APIs Revenue Share by Country (2021-2032) Figure 50. Europe Therapeutic Peptide APIs Sales Share by Country (2021-2032) Figure 51. China Therapeutic Peptide APIs Revenue Share by Type (2021-2032) Figure 52. China Therapeutic Peptide APIs Sales Share by Type (2021-2032) Figure 53. China Therapeutic Peptide APIs Revenue Share by Application (2021-2032) Figure 54. China Therapeutic Peptide APIs Sales Share by Application (2021-2032) Figure 55. Asia Therapeutic Peptide APIs Revenue Share by Type (2021-2032) Figure 56. Asia Therapeutic Peptide APIs Sales Share by Type (2021-2032) Figure 57. Asia Therapeutic Peptide APIs Revenue Share by Application (2021-2032) Figure 58. Asia Therapeutic Peptide APIs Sales Share by Application (2021-2032) Figure 59. Asia Therapeutic Peptide APIs Revenue Share by Country (2021-2032) Figure 60. Asia Therapeutic Peptide APIs Sales Share by Country (2021-2032) Figure 61. SAMEA Therapeutic Peptide APIs Revenue Share by Type (2021-2032) Figure 62. SAMEA Therapeutic Peptide APIs Sales Share by Type (2021-2032) Figure 63. SAMEA Therapeutic Peptide APIs Revenue Share by Application (2021-2032) Figure 64. SAMEA Therapeutic Peptide APIs Sales Share by Application (2021-2032) Figure 65. SAMEA Therapeutic Peptide APIs Revenue Share by Country (2021-2032) Figure 66. SAMEA Therapeutic Peptide APIs Sales Share by Country (2021-2032) Figure 67. Therapeutic Peptide APIs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Therapeutic Peptide APIs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Bioactive Peptides
  • Synthetic Peptides
Applications
  • Pharmaceuticals
  • Scientific Research
  • Other
Companies covered
  • AmbioPharm
  • Aspen API
  • Bachem
  • Bio Basic
  • CordenPharma
  • CPC Scientific
  • GenScript
  • JPT Peptide Technologies
  • Limitless Biotech
  • Lonza
  • Piramal Pharma
  • PolyPeptide
  • ScinoPharm
  • Syngene
  • USV Peptides
  • Hybio Pharmaceutical
  • Guangdong Jianyuan Pharmaceutical
  • Jiangsu Sinopep-Allsino Biopharmaceutical
  • Zhejiang Peptites Biotech
  • Cheng Du Sheng Nuo Biotec
  • Hainan Shuangcheng Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Therapeutic Peptide APIs Market by Type
  3. 1.2.1 Global Therapeutic Peptide APIs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Bioactive Peptides
  5. 1.2.3 Synthetic Peptides
  6. 1.3 Therapeutic Peptide APIs Market by Application
  7. 1.3.1 Global Therapeutic Peptide APIs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceuticals
  9. 1.3.3 Scientific Research
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Therapeutic Peptide APIs Market Dynamics
  1. 2.1 Therapeutic Peptide APIs Industry Trends
  2. 2.2 Therapeutic Peptide APIs Industry Drivers
  3. 2.3 Therapeutic Peptide APIs Industry Opportunities and Challenges
  4. 2.4 Therapeutic Peptide APIs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Therapeutic Peptide APIs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Therapeutic Peptide APIs Revenue by Region
  3. 3.2.1 Global Therapeutic Peptide APIs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Therapeutic Peptide APIs Revenue by Region (2021-2026)
  5. 3.2.3 Global Therapeutic Peptide APIs Revenue by Region (2027-2032)
  6. 3.2.4 Global Therapeutic Peptide APIs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Therapeutic Peptide APIs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Therapeutic Peptide APIs Sales by Region
  9. 3.4.1 Global Therapeutic Peptide APIs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Therapeutic Peptide APIs Sales by Region (2021-2026)
  11. 3.4.3 Global Therapeutic Peptide APIs Sales by Region (2027-2032)
  12. 3.4.4 Global Therapeutic Peptide APIs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Therapeutic Peptide APIs Revenue by Manufacturers
  2. 4.1.1 Global Therapeutic Peptide APIs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Therapeutic Peptide APIs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Therapeutic Peptide APIs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Therapeutic Peptide APIs Sales by Manufacturers
  6. 4.2.1 Global Therapeutic Peptide APIs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Therapeutic Peptide APIs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Therapeutic Peptide APIs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Therapeutic Peptide APIs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Therapeutic Peptide APIs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Therapeutic Peptide APIs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Therapeutic Peptide APIs Manufacturers, Product Type & Application
  13. 4.7 Global Therapeutic Peptide APIs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Therapeutic Peptide APIs Market CR5 and HHI
  16. 4.8.2 2025 Therapeutic Peptide APIs Tier 1, Tier 2, and Tier 3
5 Therapeutic Peptide APIs Market by Type
  1. 5.1 Global Therapeutic Peptide APIs Revenue by Type
  2. 5.1.1 Global Therapeutic Peptide APIs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Therapeutic Peptide APIs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Therapeutic Peptide APIs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Therapeutic Peptide APIs Sales by Type
  6. 5.2.1 Global Therapeutic Peptide APIs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Therapeutic Peptide APIs Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Therapeutic Peptide APIs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Therapeutic Peptide APIs Price by Type
6 Therapeutic Peptide APIs Market by Application
  1. 6.1 Global Therapeutic Peptide APIs Revenue by Application
  2. 6.1.1 Global Therapeutic Peptide APIs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Therapeutic Peptide APIs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Therapeutic Peptide APIs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Therapeutic Peptide APIs Sales by Application
  6. 6.2.1 Global Therapeutic Peptide APIs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Therapeutic Peptide APIs Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Therapeutic Peptide APIs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Therapeutic Peptide APIs Price by Application
7 Company Profiles
  1. 7.1 AmbioPharm
  2. 7.1.1 AmbioPharm Company Information
  3. 7.1.2 AmbioPharm Business Overview
  4. 7.1.3 AmbioPharm Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AmbioPharm Therapeutic Peptide APIs Product Portfolio
  6. 7.1.5 AmbioPharm Recent Developments
  7. 7.2 Aspen API
  8. 7.2.1 Aspen API Company Information
  9. 7.2.2 Aspen API Business Overview
  10. 7.2.3 Aspen API Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Aspen API Therapeutic Peptide APIs Product Portfolio
  12. 7.2.5 Aspen API Recent Developments
  13. 7.3 Bachem
  14. 7.3.1 Bachem Company Information
  15. 7.3.2 Bachem Business Overview
  16. 7.3.3 Bachem Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bachem Therapeutic Peptide APIs Product Portfolio
  18. 7.3.5 Bachem Recent Developments
  19. 7.4 Bio Basic
  20. 7.4.1 Bio Basic Company Information
  21. 7.4.2 Bio Basic Business Overview
  22. 7.4.3 Bio Basic Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bio Basic Therapeutic Peptide APIs Product Portfolio
  24. 7.4.5 Bio Basic Recent Developments
  25. 7.5 CordenPharma
  26. 7.5.1 CordenPharma Company Information
  27. 7.5.2 CordenPharma Business Overview
  28. 7.5.3 CordenPharma Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 CordenPharma Therapeutic Peptide APIs Product Portfolio
  30. 7.5.5 CordenPharma Recent Developments
  31. 7.6 CPC Scientific
  32. 7.6.1 CPC Scientific Company Information
  33. 7.6.2 CPC Scientific Business Overview
  34. 7.6.3 CPC Scientific Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 CPC Scientific Therapeutic Peptide APIs Product Portfolio
  36. 7.6.5 CPC Scientific Recent Developments
  37. 7.7 GenScript
  38. 7.7.1 GenScript Company Information
  39. 7.7.2 GenScript Business Overview
  40. 7.7.3 GenScript Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 GenScript Therapeutic Peptide APIs Product Portfolio
  42. 7.7.5 GenScript Recent Developments
  43. 7.8 JPT Peptide Technologies
  44. 7.8.1 JPT Peptide Technologies Company Information
  45. 7.8.2 JPT Peptide Technologies Business Overview
  46. 7.8.3 JPT Peptide Technologies Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 JPT Peptide Technologies Therapeutic Peptide APIs Product Portfolio
  48. 7.8.5 JPT Peptide Technologies Recent Developments
  49. 7.9 Limitless Biotech
  50. 7.9.1 Limitless Biotech Company Information
  51. 7.9.2 Limitless Biotech Business Overview
  52. 7.9.3 Limitless Biotech Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Limitless Biotech Therapeutic Peptide APIs Product Portfolio
  54. 7.9.5 Limitless Biotech Recent Developments
  55. 7.10 Lonza
  56. 7.10.1 Lonza Company Information
  57. 7.10.2 Lonza Business Overview
  58. 7.10.3 Lonza Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Lonza Therapeutic Peptide APIs Product Portfolio
  60. 7.10.5 Lonza Recent Developments
  61. 7.11 Piramal Pharma
  62. 7.11.1 Piramal Pharma Company Information
  63. 7.11.2 Piramal Pharma Business Overview
  64. 7.11.3 Piramal Pharma Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Piramal Pharma Therapeutic Peptide APIs Product Portfolio
  66. 7.11.5 Piramal Pharma Recent Developments
  67. 7.12 PolyPeptide
  68. 7.12.1 PolyPeptide Company Information
  69. 7.12.2 PolyPeptide Business Overview
  70. 7.12.3 PolyPeptide Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 PolyPeptide Therapeutic Peptide APIs Product Portfolio
  72. 7.12.5 PolyPeptide Recent Developments
  73. 7.13 ScinoPharm
  74. 7.13.1 ScinoPharm Company Information
  75. 7.13.2 ScinoPharm Business Overview
  76. 7.13.3 ScinoPharm Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 ScinoPharm Therapeutic Peptide APIs Product Portfolio
  78. 7.13.5 ScinoPharm Recent Developments
  79. 7.14 Syngene
  80. 7.14.1 Syngene Company Information
  81. 7.14.2 Syngene Business Overview
  82. 7.14.3 Syngene Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Syngene Therapeutic Peptide APIs Product Portfolio
  84. 7.14.5 Syngene Recent Developments
  85. 7.15 USV Peptides
  86. 7.15.1 USV Peptides Company Information
  87. 7.15.2 USV Peptides Business Overview
  88. 7.15.3 USV Peptides Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 USV Peptides Therapeutic Peptide APIs Product Portfolio
  90. 7.15.5 USV Peptides Recent Developments
  91. 7.16 Hybio Pharmaceutical
  92. 7.16.1 Hybio Pharmaceutical Company Information
  93. 7.16.2 Hybio Pharmaceutical Business Overview
  94. 7.16.3 Hybio Pharmaceutical Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Hybio Pharmaceutical Therapeutic Peptide APIs Product Portfolio
  96. 7.16.5 Hybio Pharmaceutical Recent Developments
  97. 7.17 Guangdong Jianyuan Pharmaceutical
  98. 7.17.1 Guangdong Jianyuan Pharmaceutical Company Information
  99. 7.17.2 Guangdong Jianyuan Pharmaceutical Business Overview
  100. 7.17.3 Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Product Portfolio
  102. 7.17.5 Guangdong Jianyuan Pharmaceutical Recent Developments
  103. 7.18 Jiangsu Sinopep-Allsino Biopharmaceutical
  104. 7.18.1 Jiangsu Sinopep-Allsino Biopharmaceutical Company Information
  105. 7.18.2 Jiangsu Sinopep-Allsino Biopharmaceutical Business Overview
  106. 7.18.3 Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Product Portfolio
  108. 7.18.5 Jiangsu Sinopep-Allsino Biopharmaceutical Recent Developments
  109. 7.19 Zhejiang Peptites Biotech
  110. 7.19.1 Zhejiang Peptites Biotech Company Information
  111. 7.19.2 Zhejiang Peptites Biotech Business Overview
  112. 7.19.3 Zhejiang Peptites Biotech Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Zhejiang Peptites Biotech Therapeutic Peptide APIs Product Portfolio
  114. 7.19.5 Zhejiang Peptites Biotech Recent Developments
  115. 7.20 Cheng Du Sheng Nuo Biotec
  116. 7.20.1 Cheng Du Sheng Nuo Biotec Company Information
  117. 7.20.2 Cheng Du Sheng Nuo Biotec Business Overview
  118. 7.20.3 Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Product Portfolio
  120. 7.20.5 Cheng Du Sheng Nuo Biotec Recent Developments
  121. 7.21 Hainan Shuangcheng Pharmaceuticals
  122. 7.21.1 Hainan Shuangcheng Pharmaceuticals Company Information
  123. 7.21.2 Hainan Shuangcheng Pharmaceuticals Business Overview
  124. 7.21.3 Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Product Portfolio
  126. 7.21.5 Hainan Shuangcheng Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Therapeutic Peptide APIs Market Size by Type
  2. 8.1.1 North America Therapeutic Peptide APIs Revenue by Type (2021-2032)
  3. 8.1.2 North America Therapeutic Peptide APIs Sales by Type (2021-2032)
  4. 8.1.3 North America Therapeutic Peptide APIs Price by Type (2021-2032)
  5. 8.2 North America Therapeutic Peptide APIs Market Size by Application
  6. 8.2.1 North America Therapeutic Peptide APIs Revenue by Application (2021-2032)
  7. 8.2.2 North America Therapeutic Peptide APIs Sales by Application (2021-2032)
  8. 8.2.3 North America Therapeutic Peptide APIs Price by Application (2021-2032)
  9. 8.3 North America Therapeutic Peptide APIs Market Size by Country
  10. 8.3.1 North America Therapeutic Peptide APIs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Therapeutic Peptide APIs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Therapeutic Peptide APIs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Therapeutic Peptide APIs Market Size by Type
  2. 9.1.1 Europe Therapeutic Peptide APIs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Therapeutic Peptide APIs Sales by Type (2021-2032)
  4. 9.1.3 Europe Therapeutic Peptide APIs Price by Type (2021-2032)
  5. 9.2 Europe Therapeutic Peptide APIs Market Size by Application
  6. 9.2.1 Europe Therapeutic Peptide APIs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Therapeutic Peptide APIs Sales by Application (2021-2032)
  8. 9.2.3 Europe Therapeutic Peptide APIs Price by Application (2021-2032)
  9. 9.3 Europe Therapeutic Peptide APIs Market Size by Country
  10. 9.3.1 Europe Therapeutic Peptide APIs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Therapeutic Peptide APIs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Therapeutic Peptide APIs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Therapeutic Peptide APIs Market Size by Type
  2. 10.1.1 China Therapeutic Peptide APIs Revenue by Type (2021-2032)
  3. 10.1.2 China Therapeutic Peptide APIs Sales by Type (2021-2032)
  4. 10.1.3 China Therapeutic Peptide APIs Price by Type (2021-2032)
  5. 10.2 China Therapeutic Peptide APIs Market Size by Application
  6. 10.2.1 China Therapeutic Peptide APIs Revenue by Application (2021-2032)
  7. 10.2.2 China Therapeutic Peptide APIs Sales by Application (2021-2032)
  8. 10.2.3 China Therapeutic Peptide APIs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Therapeutic Peptide APIs Market Size by Type
  2. 11.1.1 Asia Therapeutic Peptide APIs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Therapeutic Peptide APIs Sales by Type (2021-2032)
  4. 11.1.3 Asia Therapeutic Peptide APIs Price by Type (2021-2032)
  5. 11.2 Asia Therapeutic Peptide APIs Market Size by Application
  6. 11.2.1 Asia Therapeutic Peptide APIs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Therapeutic Peptide APIs Sales by Application (2021-2032)
  8. 11.2.3 Asia Therapeutic Peptide APIs Price by Application (2021-2032)
  9. 11.3 Asia Therapeutic Peptide APIs Market Size by Country
  10. 11.3.1 Asia Therapeutic Peptide APIs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Therapeutic Peptide APIs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Therapeutic Peptide APIs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Therapeutic Peptide APIs Market Size by Type
  2. 12.1.1 SAMEA Therapeutic Peptide APIs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Therapeutic Peptide APIs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Therapeutic Peptide APIs Price by Type (2021-2032)
  5. 12.2 SAMEA Therapeutic Peptide APIs Market Size by Application
  6. 12.2.1 SAMEA Therapeutic Peptide APIs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Therapeutic Peptide APIs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Therapeutic Peptide APIs Price by Application (2021-2032)
  9. 12.3 SAMEA Therapeutic Peptide APIs Market Size by Country
  10. 12.3.1 SAMEA Therapeutic Peptide APIs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Therapeutic Peptide APIs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Therapeutic Peptide APIs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Therapeutic Peptide APIs Value Chain Analysis
  2. 13.1.1 Therapeutic Peptide APIs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Therapeutic Peptide APIs Production Mode & Process
  6. 13.2 Therapeutic Peptide APIs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Therapeutic Peptide APIs Distributors
  9. 13.2.3 Therapeutic Peptide APIs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst